Osprey Medical Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Osprey Medical Inc. - overview

Location

Minnetonka, MN, US

Primary Industry

Medical Devices & Equipment

About

Osprey Medical is developing the CINCOR System for advanced kidney protection during coronary interventions. The CINCOR System is designed to remove dye (contrast) from the heart before it can enter the kidneys and cause damage known as contrast induced nephropathy (CIN).


Current Investors

CM Capital Investments, Brandon Capital Partners

Primary Industry

Medical Devices & Equipment

Sub Industries

Healthcare, Medical Devices & Equipment, Biomaterials

Website

www.ospreymed.com

Verticals

HealthTech

Company Stage

Mature

Total Amount Raised

Subscriber access only

Osprey Medical Inc. - financials

Fiscal Year EndedDec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019Dec 31, 2020Dec 31, 2021
Revenue (USD)585,1401,630,6152,514,117---
% Revenue Growth (YoY)-178.7%54.2%---
EBITDA (USD)(11,619,216)(14,245,318)(17,585,382)---
Operating Income (USD)(11,753,708)(14,443,190)(17,859,306)---
Operating Margin(2008.7%)(885.8%)(710.4%)---
% EBITDA Margin(1985.7%)(873.6%)(699.5%)---
NET Income (USD)(11,736,505)(14,336,411)(17,521,967)---
% Net Margin(2005.8%)(879.2%)(696.9%)---

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.